TrialsgrambetaRCTs are beautiful

PANTHER-IPF

2012

Prednisone, Azathioprine and N-Acetylcysteine in IPF

In patients with idiopathic pulmonary fibrosis, prednisone + azathioprine + NAC increased mortality and hospitalisation compared with placebo.

Result

Efficacy: Primary: change in FVC over 60 weeks (death/hospitalisation secondary)HR 12.11 (95% CI 2.83-51.85)

Below 1 favours prednisone + azathioprine + NAC, above 1 favours placebo.

Also reported: Combination vs placebo: 8 vs 1 deaths (P=0.01), 23 vs 7 hospitalisations (P<0.001); Arm stopped early. NAC monotherapy no benefit (2014).

Original publication
Subtopic
Immunosuppression: IPF
Design
Three-arm RCT, stopped early
Enrolled
155 patients
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
Idiopathic Pulmonary Fibrosis Clinical Research Network. N Engl J Med. 2012;366(21):1968-1977.doi 10.1056/NEJMoa1113354

Discussion & critique

Definitively ended the use of immunosuppression in IPF and reshaped guidelines.

Discussed in podcasts